Analysts Are Increasing Price Targets of These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target hike from analysts.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GQG Partners Rajiv Jain | 2,976,799 | $1,022,292,338 | +81% | 2.67% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 1,188,193 | $408,049,240 | +22% | 0.91% |
| 3. | 999,900 | $343,385,658 | -7% | 0.07% | |
| 4. | 756,900 | $259,934,598 | -45% | 0.05% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 689,096 | $236,649,348 | +407% | 0.5% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | Director | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | Director | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | Director | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | Director | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | Officer | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $429.46 | 6,000 | Officer | 36,941 | 2023-06-01 | Filing | |
| $447.29 | 300 | Large Shareholder | 101,473,810 | 2023-05-19 | Filing | |
| $446.65 | 4,433 | Large Shareholder | 101,474,110 | 2023-05-19 | Filing | |
| $445.50 | 2,628 | Large Shareholder | 101,478,543 | 2023-05-19 | Filing | |
| $444.40 | 6,767 | Large Shareholder | 101,481,171 | 2023-05-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 102,543,810 | $35,215,595,230 | 100% | |
| 2. | 69,988,183 | $24,035,341,806 | 0.61% | |
| 3. | 65,571,525 | $22,518,573,003 | 0.66% | |
| 4. | 33,236,143 | $11,413,939,486 | 0.64% | |
| 5. | 32,007,276 | $10,991,938,305 | 1% |
News See All
10 Stocks Jim Cramer Thinks Are Climbing In This Market
On May 9, CNBC's Mad Money host, Jim Cramer, dived into the current market dynamics to try and unravel the perplexing trends and developments we've been seeing unfold in the market so far in 2023.
15 Best Healthcare Stocks To Buy Now
In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience.
10 Stocks Jim Cramer Thinks Can Weather a Debt Default
On May 12, Jim Cramer noted the bleak market conditions, with major indices such as the Dow and the S&P 500 being down by 222 points and 0.17%, respectively.
Billionaire Stanley Druckenmiller's 2023 Portfolio: Top 5 Stock Picks
In this article, we will take a look at billionaire Stanley Druckenmiller's 2023 portfolio and his top 5 stock picks.
Louis Navellier's 2023 Portfolio: 15 Growth Stocks to Watch
In this article, we discuss 15 growth stocks to watch in Louis Navellier's 2023 portfolio.
12 Best Growth Stocks to Buy and Hold in 2023 According to Billionaire Rajiv Jain
In this article, we discuss 12 best growth stocks to buy and hold in 2023 according to billionaire Rajiv Jain.
5 Best Biotech Stocks To Buy According To Hedge Funds
Eli Lilly and Company (NYSE:LLY) is a major pharmaceutical company in the U.S.
14 Best Healthcare Dividend Stocks to Buy
In this article, we will take a look at 14 best healthcare dividend stocks to buy.
Hers’s Why Eli Lilly and Company (LLY) Declined in Q1
Fred Alger Management, an investment management company, released its “Alger Spectra Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
